PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.

Translated title of the contribution: PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.

K. Beelen, L.D.C. Hoefnagel, M. Opdam, J. Wesseling, J. Sanders, A.D. Vincent, P.J. van Diest, S.C. Linn

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.
Original languageUndefined/Unknown
Pages (from-to)1257-1263
Number of pages7
JournalInternational Journal of Cancer
Volume135
Issue number5
Publication statusPublished - 2014

Cite this